Clenbutos 40 mcg Driada Medical

£41.00

Clenbutos 40 mcg Driada Medical is a beta-2 agonist bronchodilator compound designed for advanced laboratory research into metabolic pathways and respiratory mechanisms in cellular models.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Clenbutos 40 mcg Driada Medical
Clenbutos 40 mcg Driada Medical
£41.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Clenbutos 40 mcg Driada Medical

Clenbutos 40 mcg Driada Medical is a beta-2 adrenergic receptor agonist compound specifically formulated for in-vitro laboratory research applications. This research chemical, manufactured by Driada Medical, enables scientists to investigate bronchodilation mechanisms, metabolic pathway modulation, and cellular receptor interactions in controlled laboratory environments. Researchers at Stroid UK Shop can examine this compound’s effects on beta-2 receptor binding affinity and downstream signalling cascades. The compound’s molecular structure allows for detailed studies of sympathomimetic activity and its influence on cellular metabolism in laboratory models.

Laboratory Applications

Research scientists utilise Clenbutos 40 mcg to investigate respiratory system mechanisms, examining how beta-2 agonists influence bronchial smooth muscle relaxation in tissue samples. The compound proves valuable for studying thermogenic pathways and protein synthesis modulation in cell cultures. Advanced research facilities explore its interactions with adenylyl cyclase activation and subsequent cyclic adenosine monophosphate elevation in experimental models. This research chemical complements studies conducted with other metabolic modulators to provide comprehensive data on cellular energy expenditure. Scientists can analyse receptor selectivity patterns and compare findings with other beta-agonist compounds available through selective receptor modulator research and peptide-based investigations.

Technical Specifications

Clenbutos 40 mcg Research Specifications
Active Compound Clenbuterol Hydrochloride
Concentration 40 mcg per unit
Manufacturer Driada Medical
Form Research tablets
Storage Requirements Cool, dry conditions
Research Grade Laboratory standard

Research Compliance Statement

Clenbutos 40 mcg Driada Medical is manufactured exclusively for in-vitro research purposes and laboratory analysis. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols and safety procedures when handling this compound for experimental studies.

Related